Literature DB >> 35640018

Chemokines form nanoparticles with DNA and can superinduce TLR-driven immune inflammation.

Yong Du1,2, Marie Dominique Ah Kioon1, Paoline Laurent1,2, Vidyanath Chaudhary1,2, Michael Pierides1, Chao Yang1, David Oliver1,3, Lionel B Ivashkiv1,3,4, Franck J Barrat1,2,3.   

Abstract

Chemokines control the migratory patterns and positioning of immune cells to organize immune responses to pathogens. However, many chemokines have been associated with systemic autoimmune diseases that have chronic IFN signatures. We report that a series of chemokines, including CXCL4, CXCL10, CXCL12, and CCL5, can superinduce type I IFN (IFN-I) by TLR9-activated plasmacytoid DCs (pDCs), independently of their respective known chemokine receptors. Mechanistically, we show that chemokines such as CXCL4 mediate transcriptional and epigenetic changes in pDCs, mostly targeted to the IFN-I pathways. We describe that chemokines physically interact with DNA to form nanoparticles that promote clathrin-mediated cellular uptake and delivery of DNA in the early endosomes of pDCs. Using two separate mouse models of skin inflammation, we observed the presence of CXCL4 associated with DNA in vivo. These data reveal a noncanonical role for chemokines to serve as nucleic acid delivery vectors to modulate TLR signaling, with implications for the chronic presence of IFN-I by pDCs in autoimmune diseases.
© 2022 Du et al.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35640018      PMCID: PMC9161158          DOI: 10.1084/jem.20212142

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   17.579


  55 in total

1.  Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling.

Authors:  Marie-Alice Meuwis; Marianne Fillet; Pierre Geurts; Dominique de Seny; Laurence Lutteri; Jean-Paul Chapelle; Vincent Bours; Louis Wehenkel; Jacques Belaiche; Michel Malaise; Edouard Louis; Marie-Paule Merville
Journal:  Biochem Pharmacol       Date:  2006-12-20       Impact factor: 5.858

2.  STAR: ultrafast universal RNA-seq aligner.

Authors:  Alexander Dobin; Carrie A Davis; Felix Schlesinger; Jorg Drenkow; Chris Zaleski; Sonali Jha; Philippe Batut; Mark Chaisson; Thomas R Gingeras
Journal:  Bioinformatics       Date:  2012-10-25       Impact factor: 6.937

3.  Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma.

Authors:  T Yamamoto; S Takagawa; I Katayama; K Yamazaki; Y Hamazaki; H Shinkai; K Nishioka
Journal:  J Invest Dermatol       Date:  1999-04       Impact factor: 8.551

4.  Liquid-crystalline ordering of antimicrobial peptide-DNA complexes controls TLR9 activation.

Authors:  Nathan W Schmidt; Fan Jin; Roberto Lande; Tine Curk; Wujing Xian; Calvin Lee; Loredana Frasca; Daan Frenkel; Jure Dobnikar; Michel Gilliet; Gerard C L Wong
Journal:  Nat Mater       Date:  2015-06-08       Impact factor: 43.841

5.  Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide.

Authors:  Roberto Lande; Josh Gregorio; Valeria Facchinetti; Bithi Chatterjee; Yi-Hong Wang; Bernhard Homey; Wei Cao; Yui-Hsi Wang; Bing Su; Frank O Nestle; Tomasz Zal; Ira Mellman; Jens-Michael Schröder; Yong-Jun Liu; Michel Gilliet
Journal:  Nature       Date:  2007-09-16       Impact factor: 49.962

6.  Mechanism of action of polymeric aurintricarboxylic acid, a potent inhibitor of protein--nucleic acid interactions.

Authors:  R G González; R S Haxo; T Schleich
Journal:  Biochemistry       Date:  1980-09-02       Impact factor: 3.162

Review 7.  Importance of Nucleic Acid Recognition in Inflammation and Autoimmunity.

Authors:  Franck J Barrat; Keith B Elkon; Katherine A Fitzgerald
Journal:  Annu Rev Med       Date:  2015-11-02       Impact factor: 13.739

8.  Structural perspectives on antimicrobial chemokines.

Authors:  Leonard T Nguyen; Hans J Vogel
Journal:  Front Immunol       Date:  2012-12-28       Impact factor: 7.561

9.  CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis.

Authors:  Roberto Lande; Ernest Y Lee; Raffaella Palazzo; Barbara Marinari; Immacolata Pietraforte; Giancarlo Santiago Santos; Yves Mattenberger; Francesca Spadaro; Katia Stefanantoni; Nicoletta Iannace; Aleksandra Maria Dufour; Mario Falchi; Manuela Bianco; Elisabetta Botti; Luca Bianchi; Montserrat Alvarez; Valeria Riccieri; Marie-Elise Truchetet; Gerard C L Wong; Carlo Chizzolini; Loredana Frasca
Journal:  Nat Commun       Date:  2019-05-01       Impact factor: 14.919

10.  Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus.

Authors:  Jodi L Karnell; Yanping Wu; Nanette Mittereder; Michael A Smith; Michele Gunsior; Li Yan; Kerry A Casey; Jill Henault; Jeffrey M Riggs; Simone M Nicholson; Miguel A Sanjuan; Katherine A Vousden; Victoria P Werth; Jörn Drappa; Gabor G Illei; William A Rees; John N Ratchford
Journal:  Sci Transl Med       Date:  2021-05-26       Impact factor: 17.956

View more
  1 in total

1.  Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses.

Authors:  Vidyanath Chaudhary; Marie Dominique Ah Kioon; Sung-Min Hwang; Bikash Mishra; Kimberly Lakin; Kyriakos A Kirou; Jeffrey Zhang-Sun; R Luke Wiseman; Robert F Spiera; Mary K Crow; Jessica K Gordon; Juan R Cubillos-Ruiz; Franck J Barrat
Journal:  J Exp Med       Date:  2022-09-02       Impact factor: 17.579

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.